GSK
First new asthma treatment in a decade
There is new hope for those with “difficult to treat” asthma in the new year, with breakthrough biologic to be PBS listed on 1 Jan Nucala (mepolizumab) is the first …
Pressure mounts for lower vaccine prices
Last month, Médecins Sans Frontières (MSF) surprised Pfizer by refusing a donation of one million doses of the company’s pneumonia vaccine With high numbers of children who are not immunised against …
GSK is API’s Supplier of the Year
Australian Pharmaceutical Industries Limited has named GSK as Supplier of the Year, at API’s annual Supplier Excellence Awards in Melbourne. API’s CEO and MD, Stephen Roche, said that GSK’s continuous …
GSK in the clear
Panadol Osteo pricing statement ambiguous, but not false or misleading: ACCC The Australian Competition and Consumer Commission has concluded its investigation into whether GlaxoSmithKline (GSK) made misleading statements about a …
NPS MedicineWise rejects ‘selling out’ to big pharma claim
The not-for-profit vehemently denies claims by leading medical publication that it has “sold its soul to big pharma” CEO Dr Lynn Weekes has written a lengthy letter hitting back at …
GSK tops Fortune list of world-changing companies
The pharmaceutical giant was ranked first for its “unmatched record for balancing scientific progress, social impact and the profit motive” Fortune magazine and a panel of experts recently named GlaxoSmithKline the …
Hayfever impact underestimated
The impact of hayfever on quality of life is often underestimated, says one expert. Dr Mimi Tang, allergy specialist at the Murdoch Children’s Research Institute, told the AJP that even …
Patent dispute over generic paracetamol on hold
Initial claims have been dismissed, but there is an opportunity to make further submissions on both sides GlaxoSmithKline’s legal proceeding against Apotex and Generic Partners over its paracetamol products has …
GSK partners with Government on quadrivalent flu jab
GSK Australia is partnering with the Australian Government to provide a quadrivalent influenza vaccine for the National Immunisation Program for the 2016 season. Fluarix® Tetra is a four-strain flu vaccine …
GSK, Novartis get ACCC okay to restructure
The Australian Competition and Consumer Commission says it won’t oppose GlaxoSmithKline’s and Novartis’ transactions involving over-the-counter consumer products, human vaccines and oncology products. As a result of the transactions: GSK …
Manufacturers get optimising
META, a collaborative network of manufacturing businesses and researchers, today announced a collaborative project between Hospira, GlaxoSmithKline and CSL to generate a targeted 3% productivity boost with an estimated return …